TidalSense
Generated by Meeveem AI
"Transforming respiratory care with AI-driven diagnostics for COPD and asthma"
Cambridge
•11 - 50 Employees
•Diagnostics
About TidalSense
TidalSense develops AI-powered diagnostic and monitoring technologies for chronic respiratory conditions, focusing on COPD and asthma. The company's N-Tidal platform combines a patented CO2 sensor, handheld devices, and cloud-based artificial intelligence to deliver rapid point-of-care diagnostics. This technology enables clinicians to diagnose COPD in just five minutes from relaxed breathing, addressing the fact that 67% of COPD patients remain undiagnosed. Founded in 2013 and based in Cambridge, TidalSense partners with healthcare providers, payers, and pharmaceutical companies to transform respiratory care pathways, preventing costly hospitalisations through earlier diagnosis and personalised intervention.
31
Team Members
2013
Founded
Diagnostics
Sector
Hybrid
Work Environment
Our Vision
A world where respiratory conditions are diagnosed early and managed proactively, preventing hospitalisations and drastically improving outcomes for the nearly 10% of the global population affected by COPD and asthma.
Our Mission
At TidalSense, our mission is to revolutionise population-level outcomes for respiratory patients through pathway transformation, delivering faster, more precise diagnosis and management capabilities at the front lines of care.